Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
International
International Disclosure Laws: Managing Consent Within EFPIA’s Disclosure…
The EFPIA Disclosure Code requires all member companies of EFPIA, the European Federation of Pharmaceutical Industries…
European Medicines Agency Inching Towards Clinical Trial Transparency
The European Medicines Agency (EMA) Management Board has been inching towards a policy on clinical trial transparency.…
Medicines Australia Code of Conduct: Payment Reporting Starts October 1,…
Transparency is increasingly a global phenomenon. Australia is no exception. Medicines Australia, Australia's industry…
China Bribery Probe: GSK Manager Charged with Corruption; Concerned Pharma…
The Chinese bribery allegations against GlaxoSmithKline (GSK) have taken a scary turn for pharmaceutical executives…
EFPIA Disapproves of French Off-Label Initiative
On July 8, 2014, the French National Assembly voted a draft law proposal that would potentially allow healthcare…
Global Healthcare Compliance Outlook: Middle East and Africa Code of…
The Eighth International Pharmaceutical Compliance Congress took place in Dubai, UAE earlier this year. The conference…
EFPIA Launches “Pharma Disclosure” Website; Provides Template Disclosure…
Starting in 2016, European Federation of Pharmaceutical Industries and Associations (EFPIA) member companies will make public…
India Compliance Best Practice Overview
The Eighth International Pharmaceutical Compliance Congress took place in Dubai, UAE from May 5-7. The conference…
French Sunshine Act: Public Database Published
As we've said a lot this year, transparency is a global phenomenon. The Loi Bertrand, or the French Sunshine Act, is similar in…
Pakistan Looks to Increase Transparency between Healthcare Providers and…
Pakistan may be the latest country onsidering increasing transparency in interactions between healthcare providers and industry.…